India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
India in the Changing Landscape of Life-Sciences Research & Development
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Subscribe To Our Newsletter & Stay Updated